Abexol and Atorvastatin in the non alcoholic steatohepatitis
Phase 4
- Conditions
- on-Alcoholic Steatohepatitis (NASH)Non-alcoholic Fatty Liver DiseaseFatty LiverLiver DiseasesDigestive System Diseases
- Registration Number
- RPCEC00000221
- Lead Sponsor
- Center of Natural Products, National Center for Scientific Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1- Patients with confirmatory biopsy of non alcoholic steatohepatitis
Exclusion Criteria
1-Actual consuming of alcohol.
2-Infection by C and B virus.
3-Autoinmune hepatopaties.
4-Hemocromatosis.
5.Hepatoxicity.
6-VIH.
7-Secundary cause of NASH.
8-Pregnant women, women project being pregnant or who are breastfeeding.
9-Uncompensated diabetic patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Histological improvement (Kleiner Index 0-11points). Measuring time: before starting treatment and at the end of the 24 weeks <br>Insulinoreseistence improvement (HOMA2-IR) . Measuring time: before starting treatment and at the end of the 24 weeks
- Secondary Outcome Measures
Name Time Method